๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

520 First-line chemotherapy with carboplatin, cisplatin and cyclophosphamide (C.C.C) in advanced ovarian cancer (AOC)

โœ Scribed by D.Z. Edelmann; T. Peretz; V. Barak; S.O. Anteby

Book ID
116167273
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
163 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Ifosfamide, paclitaxel and cisplatin fir
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer
โœ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 97 KB ๐Ÿ‘ 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th

First-line combination chemotherapy with
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer
โœ P. Periti; G. Robustelli Delia Cuna; F. Pannuti; T. Mazzei; P. Preti; A. Martoni ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 312 KB

In this study, 30 evaluable patients with advanced carcinoma of the breast were treated with cyclophosphamide 600 mg/m2 i.v. followed one day later with mitoxantrone (Novantrone; dihydroxyanthracenedione) 16 mg/m2 i.v. Drug treatment was repeated every 3-4 weeks, for a maximum of 12 cycles. The over